BMS To Pay $2.1M To Settle FTC's Plavix Claims

Law360, New York (March 27, 2009, 12:00 AM EDT) -- Bristol-Myers Squibb Co. has agreed to fork over $2.1 million to settle allegations by the U.S. Federal Trade Commission that the drugmaker issued misleading statements about a proposed Plavix patent deal with Apotex Corp. in 2006, violating court orders stemming from two earlier antitrust cases.

The deal will lay to rest a lawsuit filed Thursday by the FTC in the U.S. District Court for the District of Columbia accusing Bristol-Myers of concealing material information about its agreement with the Canadian pharmaceutical company to keep a copycat...
To view the full article, register now.